Blueprint Medicines Corporation

NASDAQ:BPMC

86 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 138.15796.11671.95756.56657.5763.28738.78165.97736.54762.731107.02224.18827.29521.57634.107745.1188.3436.16751.5339.1395.110.731.0331.09541.4390.9541.6288.0685.895.847.6916.167.0656.8564.6353.4262.6870.6520000
Cost of Revenue 11.218.0011.7914.5532.3233.1754.84834.8865.0797.5493.796.4930.1020.1280.1460.1270.02488.64681.45387.10174.2570.53264.56258.57349.95443.62939.333.27128.48724.07318.1521.27317.63516.43111.68111.2439.23211.3338.3686.7625.381
Gross Profit 126.94788.11570.16652.01355.24760.11233.93362.97731.66157.65299.47320.39820.80221.47433.979744.9728.2166.143-37.113-72.314-81.991-73.52-69.499-63.467-17.134-49-42.001-31.232-27.381-22.647-16.382-11.99-14.208-10.779-11.796-8.255-8.556-8.58-11.333-8.368-6.762-5.381
Gross Profit Ratio 0.9190.9170.9750.920.960.950.8750.9550.8660.9190.9290.8430.7620.9950.99610.9850.996-0.72-7.913-16.045-100.712-67.279-57.961-0.413-51.363-25.799-3.871-4.649-3.878-2.13-1.946-2.011-1.572-2.545-2.41-3.184-13.160000
Reseach & Development Expenses 80.65383.38196.006110.252110.063112.073117.84127.981128.466103.133356.87784.41980.02779.7177.40574.2391.07984.14688.64681.45387.10174.2570.53264.56258.57349.95443.62939.333.27128.48724.07318.1521.27317.63516.43211.68111.2439.23211.3338.3686.7625.381
General & Administrative Expenses 66.63166.62762.3757.6753.21260.945.91949.8890040.69900035.6550035.65532.26525.64721.92316.55313.64312.04112.3339.9118.0927.3786.8335.6834.9914.8934.6884.6463.6244.2223.842.772.9611.9211.4371.572
Selling & Marketing Expenses 22.70816.9316.913.07118.71910.0518.17.7190013.50006.8860003.300000000000000000000000
SG&A 89.33983.55779.2770.74171.93170.9564.01957.60858.68857.05854.19949.80649.28642.00242.54137.37542.17435.65532.26525.64721.92316.55313.64312.04112.3339.9118.0927.3786.8335.6834.9914.8934.6884.6463.6244.2223.842.772.9611.9211.4371.572
Other Expenses -0.0010.376-0.577-0.728-0.6261.2961.8721.6652.1453.265-0.381-0.522-0.373-0.2140.05-0.192-0.023-0.2010.0573.6924.2352.6692.8252.7992.4422.3941.1080.9540.8610.4250.2010.1580.1310.0610.0060.006-0.405-0.037-0.023-0.0940.0010.018
Operating Expenses 169.992166.938175.276180.993183.228184.319183.731187.254189.299163.456415.607137.494129.313121.712119.946111.605133.253119.801120.911107.1109.02490.80384.17576.60370.90659.86551.72146.67840.10434.1729.06423.04325.96122.28120.05615.90315.08312.00214.29410.2898.1996.953
Operating Income -43.045-78.823-105.11-128.98-127.981-135.379-156.814-124.277-157.638-105.804-316.053-117.096-108.511-100.238-85.966633.367-125.037-113.658-69.378-97.961-103.914-90.073-83.142-75.508-29.467-58.911-50.093-38.61-34.214-28.33-21.373-16.883-18.896-15.425-15.42-12.477-12.396-11.35-14.294-10.289-8.199-6.953
Operating Income Ratio -0.312-0.82-1.461-2.28-2.223-2.139-4.044-1.884-4.313-1.687-2.953-4.841-3.975-4.646-2.520.85-14.987-18.43-1.346-10.719-20.335-123.388-80.486-68.957-0.711-61.752-30.77-4.786-5.809-4.851-2.779-2.741-2.675-2.25-3.327-3.642-4.613-17.4080000
Total Other Income Expenses Net -6.847168.139-5.747-4.536-0.6266.339-0.789-81.059-0.011-0.381-0.522-0.373-0.2140.05-0.192-0.023-0.2010.0573.6924.2352.6692.8252.7992.4422.3941.1080.9540.8610.4250.2010.1580.1310.0610.0060.006-0.405-0.037-0.023-0.0940.0010.018
Income Before Tax -49.89289.316-110.857-133.516-132.603-129.04-157.603-132.277-156.579-105.815-316.052-117.066-108.251-99.714-84.981634.348-123.474-110.955-66.331-94.275-99.681-87.407-80.322-72.723-27.048-56.549-49.027-37.703-33.412-27.977-21.263-16.834-18.894-15.504-15.575-12.642-12.98-11.572-14.468-10.503-8.287-7.027
Income Before Tax Ratio -0.3610.929-1.541-2.36-2.303-2.039-4.064-2.005-4.284-1.687-2.953-4.84-3.966-4.622-2.4920.851-14.8-17.992-1.287-10.316-19.507-119.736-77.756-66.414-0.653-59.276-30.115-4.673-5.673-4.791-2.765-2.733-2.674-2.261-3.36-3.69-4.831-17.7480000
Income Tax Expense 0.1020.180.0610.1970.190.521.0360.8863.130.1842.6350.1750.193-0.7380.6880.37-3.254-2.904-0.9153.6984.2372.6721.662.8132.4652.4260.7591.0010.920.497-0.1010.2670.260.201-0.1670.177-0.2260.1480.1280.0260.090.11
Net Income -49.99489.136-110.918-133.713-132.793-129.56-158.639-133.163-159.709-105.999-318.687-117.241-108.444-99.714-85.669633.978-123.474-110.955-66.331-94.275-99.681-87.407-80.322-72.723-27.048-56.549-49.027-37.703-33.412-27.977-21.263-16.834-18.894-15.504-15.575-12.642-12.98-11.572-14.468-10.503-8.287-7.027
Net Income Ratio -0.3620.927-1.541-2.364-2.307-2.047-4.091-2.018-4.37-1.69-2.978-4.847-3.973-4.622-2.5120.851-14.8-17.992-1.287-10.316-19.507-119.736-77.756-66.414-0.653-59.276-30.115-4.673-5.673-4.791-2.765-2.733-2.674-2.261-3.36-3.69-4.831-17.7480000
EPS -0.81.45-1.82-2.2-2.19-2.15-2.65-2.23-2.68-1.79-5.4-2-1.86-1.72-1.5311.49-2.28-2.11-1.35-1.93-2.04-1.98-1.83-1.66-0.62-1.29-1.23-0.96-0.86-0.84-0.75-0.62-0.7-0.57-0.58-0.47-0.76-0.47-0.58-0.8-0.63-0.54
EPS Diluted -0.81.4-1.82-2.2-2.19-2.15-2.65-2.23-2.68-1.79-5.4-2-1.86-1.72-1.5311.16-2.28-2.11-1.35-1.93-2.04-1.98-1.83-1.66-0.62-1.29-1.23-0.96-0.86-0.84-0.75-0.62-0.7-0.57-0.58-0.47-0.76-0.47-0.58-0.8-0.63-0.54
EBITDA -39.428-74.013-103.579-128.98-127.981-123.221-149.798-122.656-156.168-104.176-316.134-115.48-106.919-98.63-85.967635.015-125.037-112.087-69.378-91.664-97.169-85.185-80.317-71.546-25.892-55.737-48.985-37.26-32.96-27.507-21.172-16.318-18.369-14.978-15.415-12.267-12.599-11.178-14.111-10.24-8.059-6.801
EBITDA Ratio -0.285-0.77-1.439-2.28-2.223-1.947-3.863-1.859-4.273-1.661-2.954-4.774-3.917-4.571-2.5210.852-14.987-18.175-1.346-10.03-19.015-116.692-77.751-65.339-0.625-58.425-30.089-4.618-5.596-4.71-2.753-2.649-2.6-2.185-3.326-3.581-4.689-17.1440000